Analysis of the GENT2 gene expression database (gent2.appex.kr) encompassing over 68,000 samples from 72 different tissues (Park et al, 2019) revealed significantly higher levels of SMARCA4 mRNA in all-cancers compared to all-normal tissues in two different datasets (Appendix Fig. S1A), while SMARCA2 mRNA levels were significantly lower in all-cancers compared to all-normal tissues in two different datasets (Appendix Fig. S1B). This evidence concerns the gene SMARCA2 and cancer.